ORIGINAL ARTICLE |
|
Year : 2019 | Volume
: 32
| Issue : 1 | Page : 352-358 |
|
Therapeutic effects of human stem cells in experimentally induced acute kidney injury in rats
Mahmoud A El-Aziz Kora1, Ahmed M Zahran1, Ahmed R Tawfiq1, Yahya M. Naguib Abd El-Salam2, Hussain M Hussain Kholaif3
1 Department of Internal Medicine, Faculty of Medicine, Menoufia University, Menoufia, Egypt 2 Department of Clinical Physiology, Faculty of Medicine, Menoufia University, Menoufia, Egypt 3 Department of Internal Medicine, Ashmoun Central Hospital, Menoufia, Egypt
Correspondence Address:
Hussain M Hussain Kholaif Ashmoun 24582, Menoufia Governorate Egypt
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/mmj.mmj_530_17
|
|
Objective
The aim of this study was to evaluate the effect of stem cell therapy in drug-induced acute kidney injury in rats.
Background
Acute kidney injury (AKI) is defined as a rapid decrease in renal functions within few days; thus drug-induced AKI is a frequent entity in clinical medicine. Stem cell therapy provides a hopeful prospective for injured tissues and for repairing damaged organs.
Materials and methods
A total of 30 male Swiss albino rats were used in the present study. The animals were randomly divided into three groups. Group I: control group (10 rats). Group II: AKI group (10 rats), gentamicin-induced AKI rat models were used. Group III: stem-cell-treated AKI group (10 rats). Rats with established AKI were injected with CD34-positive stem cells. The three studied groups were assessed for serum urea, blood urea nitrogen, serum creatinine, and kidney injury molecule 1 (KIM-1). At the end, all the rats were killed and their kidneys were excised for histopathology and immunohistochemical studies.
Results
Serum KIM-1 level was significantly higher in the AKI group in comparison with both control group and stem-cell-treated group (P = 0.001), whereas no statistically significant difference was found between control group and stem-cell-treated group regarding serum KIM-1 level (P = 0.755). The results of the immunohistopathological studies have shown no significant changes between control group and AKI-stem-cell-treated group.
Conclusion
This study showed that AKI markers improved after treatment by stem cells in AKI-induced group.
|
|
|
|
[FULL TEXT] [PDF]* |
|
|
|